NEW YORK STATE COMMON RETIREMENT FUND - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 75 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,000
-98.1%
259
-98.9%
0.00%
Q1 2021$53,000
-1.9%
24,3000.0%0.00%
Q4 2020$54,000
-16.9%
24,3000.0%0.00%
Q3 2020$65,000
-12.2%
24,3000.0%0.00%
Q2 2020$74,000
+54.2%
24,3000.0%0.00%
Q1 2020$48,000
-30.4%
24,3000.0%0.00%
Q4 2019$69,000
-22.5%
24,3000.0%0.00%
Q3 2019$89,000
-35.5%
24,300
-26.8%
0.00%
Q2 2019$138,000
+711.8%
33,200
+225.5%
0.00%
Q4 2015$17,000
-29.2%
10,2000.0%0.00%
Q3 2015$24,000
-57.9%
10,200
-51.3%
0.00%
Q2 2015$57,000
+67.6%
20,940
+105.3%
0.00%
Q1 2015$34,00010,2000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$222,0000.08%
Geneos Wealth Management Inc. 478,067$626,0000.03%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$16,0000.01%
Atria Wealth Solutions, Inc. 281,700$369,0000.01%
Vivaldi Capital Management LP 17,078$22,0000.01%
OSAIC HOLDINGS, INC. 1,284,481$1,684,0000.00%
Ameritas Advisory Services, LLC 45,302$59,0000.00%
CENTAURUS FINANCIAL, INC. 20,947$27,0000.00%
Summit Trail Advisors, LLC 23,855$31,0000.00%
WEDBUSH SECURITIES INC 27,998$37,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders